FundedIQ
Biotechnology

Acenxion Biosystems: Funding, Investors & Team (Oct 2026)

Acenxion Biosystems is a company that is funded privately and focuses on creating automated systems for testing the susceptibility of microbes to antibiotics and detecting bacteria in blood samples. Their fAST system can be easily integrated into existing clinical practices and shortens the time needed for testing to 4-6 hours. This helps clinicians quickly identify the best treatment for patients, leading to better outcomes, lower healthcare expenses, and reduced antibiotic resistance. Ultimately, Acenxion's technology helps extend the effectiveness of antibiotics.

www.acenxionbiosystems.com LinkedIn Kansas City, United States 1-10 employees
Biotechnology Life Science Medical Precision Medicine B2B
Total raised
$1.1M
Rounds
1
Latest
Seed
Aug 2024

Acenxion Biosystems has raised $1.1M across 1 funding round on record, the most recent a Seed of $1.1M announced in Aug 2024.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Acenxion Biosystems Company Profile and Key Stats

Total funding raised
$1.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$1.1M in Aug 2024
Employees
1-10
reported band
Headquarters
Kansas City, United States

Latest funding round on record: Aug 2024.

Acenxion Biosystems Funding Rounds

Date
Round
Amount
Seed
$1.1M

Acenxion Biosystems Founders and Leadership Team

Name
Role
Contact
Roy Swiger
Founder
—

No contact details are on record for this team yet.

Acenxion Biosystems Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
17,153
$3.1M

Acenxion Biosystems' latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Acenxion Biosystems in Biotechnology and Kansas City

Companies Similar to Acenxion Biosystems

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Acenxion Biosystems Funding FAQs

What does Acenxion Biosystems do?

Acenxion Biosystems is a company that is funded privately and focuses on creating automated systems for testing the susceptibility of microbes to antibiotics and detecting bacteria in blood samples. Their fAST system can be easily integrated into existing clinical practices and shortens the time needed for testing to 4-6 hours. This helps clinicians quickly identify the best treatment for patients, leading to better outcomes, lower healthcare expenses, and reduced antibiotic resistance. Ultimately, Acenxion's technology helps extend the effectiveness of antibiotics.

How much funding has Acenxion Biosystems raised?

Acenxion Biosystems has raised $1.1M across 1 round on record. The most recent is a Seed of $1.1M announced in Aug 2024.

When did Acenxion Biosystems last raise funding?

Acenxion Biosystems' most recent funding round on record is a Seed of $1.1M, announced in Aug 2024.

Who founded Acenxion Biosystems?

FundedIQ lists Roy Swiger (Founder) at Acenxion Biosystems.

Where is Acenxion Biosystems headquartered?

Acenxion Biosystems is based in Kansas City, Kansas, United States.

How many employees does Acenxion Biosystems have?

Acenxion Biosystems is in the 1-10 employee band.

How does Acenxion Biosystems' funding compare to other Biotechnology startups?

Acenxion Biosystems' latest round of $1.1M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Acenxion Biosystems Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acenxion Biosystems is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.